Journal of the American Society of Hypertension
Volume 4, Issue 5 , Pages 211-214 , September 2010

Central blood pressure measurements—an opportunity for efficacy and safety in drug development?

  • Raymond R. Townsend, MD

      Affiliations

    • University of Pennsylvania, Philadelphia, Pennsylvania, USA
    • Corresponding Author InformationCorresponding author: Raymond R. Townsend, MD, University of Pennsylvania, 122 Founders Building, 3400 Spruce Street, Philadelphia, Pennsylvania 19104. Tel: 215–662–4630; fax: 215–662–3459.
    • ,
  • Mary J. Roman, MD

      Affiliations

    • Weill Cornell Medical College, New York, New York, USA
    • ,
  • Samer S. Najjar, MD

      Affiliations

    • Washington Hospital Center, Washington, DC, USA
    • ,
  • John R. Cockcroft, MD

      Affiliations

    • Wales Heart Institute, Cardiff, Wales, UK
    • ,
  • Peter U. Feig, MD

      Affiliations

    • Merck & Co., Rahway, New Jersey, USA
    • ,
  • Norman L. Stockbridge, MD, PhD

      Affiliations

    • Food and Drug Administration, Rockville, Maryland, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1933-1711(10)00159-2

doi: 10.1016/j.jash.2010.07.002

Journal of the American Society of Hypertension
Volume 4, Issue 5 , Pages 211-214 , September 2010

Article Tools

* Image Usage & Resolution